AgeX Therapeutics Licensee ImStem Biotechnology Announces FDA has Lifted the Hold and Cleared the Investigational New Drug Application for IMS001 for the Treatment of Multiple Sclerosis
Stock Information for Credit Suisse Agriculture Index
Loading
Please wait while we load your information from QuoteMedia.